Avicanna Inc. (AVCNF) Financials
AVCNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 17.0 million | 7.1 million |
| March 31, 2026 | 15.9 million | 6.7 million |
| Dec. 31, 2025 | 15.5 million | 7.2 million |
| Sept. 30, 2025 | 15.2 million | 6.8 million |
AVCNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -935161 | ? |
| March 31, 2026 | -696936 | 49297 |
| Dec. 31, 2025 | -144980 | 259384 |
| Sept. 30, 2025 | -621358 | 311231 |
AVCNF Net Income
No data available :(
AVCNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 141121 | - | - |
| March 31, 2026 | 267531 | - | - |
| Dec. 31, 2025 | 204524 | - | - |
| Sept. 30, 2025 | 239697 | - | - |
AVCNF Shares Outstanding
AVCNF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 115009 | 8889 | 2.9 million | - |
| March 31, 2026 | 9337 | 11498 | 2.9 million | 687326 |
| Dec. 31, 2025 | 5739 | 41335 | 3.0 million | 725197 |
| Sept. 30, 2025 | 16281 | 23051 | 3.1 million | 623093 |
AVCNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 4.0 million | 1.9 million |
| March 31, 2026 | 4.8 million | 2.3 million |
| Dec. 31, 2025 | 4.8 million | 2.3 million |
| Sept. 30, 2025 | 4.6 million | 2.3 million |
AVCNF
Price: $0.07
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -6.85
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 8.9 million